Regeneron Pharmaceuticals Inc. Stock Performance
as on August 4, 2026 at 1:08 am IST
Day's Low
Day's High
$759.25$771.95
0.62%
Downside
1.04%
Upside

52 Week's Low
52 Week's High
$541.00$821.11
29.19%
Downside
7.48%
Upside

Regeneron Pharmaceuticals Inc. share price movements today
- Previous Close
- $762.63
- Open
- $770.09
- Volume
- 65.2K
- Day's Low - High
- $759.25 - $771.95
- 52 Week Low - High
- $541.00 - $821.11
Regeneron Pharmaceuticals Inc. Historical Returns
- 1 Month Return
- + 16.56 %
- 3 Month Return
- + 8.73 %
- 1 Year Return
- + 36.46 %
- 3 Year Return
- -1.14 %
- 5 Year Return
- + 30.03 %
Regeneron Pharmaceuticals Inc. Stock Fundamentals & Key Indicators
Check Regeneron Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$78.5B
EPS (TTM)
52.5993
Dividend Yield
0.49%
Quarterly Earnings Growth YOY
-0.04%
PE Ratio (TTM)
18.87
Industry PE ratio
4.805185185185185
PEG Ratio
1.3436
EBITDA
4.7B
Revenue (TTM)
15.5B
Profit Margin
27.87%
Return On Equity TTM
14.04%
Regeneron Pharmaceuticals Inc. Stock Valuation
Track how Regeneron Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Regeneron Pharmaceuticals Inc. in the last 5 years
Lowest (8.22x)
December 31, 2021
Industry (4.81x)
August 3, 2026
Today (18.87x)
August 3, 2026
Highest (24.50x)
September 30, 2024
Today’s Price to Earnings Ratio: 18.87x
Regeneron Pharmaceuticals Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Regeneron Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $78.5B | 30.03% | 18.87 | 27.87% | 0.49% | |
| BUY | $39.9B | 535.48% | NA | 0.00% | NA | |
| BUY | $121.1B | 138.49% | 28.33 | 35.51% | NA |
Stock Returns calculator for Regeneron Pharmaceuticals Inc. Stock including INR - Dollar returns
The Regeneron Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Regeneron Pharmaceuticals Inc. investment value today
Current value as on today
₹1,48,636
Returns
₹48,636
(+48.64%)
Returns from Regeneron Pharmaceuticals Inc. Stock
₹36,701 (+36.7%)
Dollar Impact
₹11,935 (+11.93%)
Analyst Recommendation on Regeneron Pharmaceuticals Inc. Stock
Based on 34 analysts
76.47%
Buy
20.59%
Hold
2.94%
Sell
Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Regeneron Pharmaceuticals Inc.. Average target price of $833.54
Regeneron Pharmaceuticals Inc. Share Price Target
Get share price movements and forecasts by analysts on Regeneron Pharmaceuticals Inc..
What analysts predicted
8.35%UPSIDE
Target Price
$833.54
Current Price
$763.98
Analyzed by
34 Analysts
Target
$833.54
Regeneron Pharmaceuticals Inc. target price $833.54, a slight upside of 8.35% compared to current price of $763.98. According to 34 analysts rating.
Indian Investors' Interest in Regeneron Pharmaceuticals Inc. Stock
Investment in Regeneron Pharmaceuticals Inc. Shares on INDmoney has grown by 129.62% in the last 30 days, indicating increased investment activity.
Time period: to
Change:129.62%Â versus previous 30 day period
Search interest for Regeneron Pharmaceuticals Inc. Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:13%Â versus previous 30 day period
Regeneron Pharmaceuticals Inc. Quarterly Profit & Loss
All numbers in Millions USD
Regeneron Pharmaceuticals Inc. Annual Profit & Loss
All numbers in Millions USD
Regeneron Pharmaceuticals Inc. Quarterly Cash Flow
All numbers in Millions USD
Regeneron Pharmaceuticals Inc. Annual Cash Flow
All numbers in Millions USD
Regeneron Pharmaceuticals Inc. News & Key Events

Today's Timeline - 31 July
Fri, 09:36 AM
-Regeneron reports strong Q2 2026 growth, productive talks with Sanofi to expand collaboration on Dupixent follow-on programs.
Insights on Regeneron Pharmaceuticals Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike

Regeneron Pharmaceuticals, Inc. has shown strong financial performance, with its net profit increasing for the last two quarters. It rose from $727.20 million to $1.29 billion, demonstrating an average increase of 43.9% each quarter.
POSITIVE IMPACTRevenue Rich

Regeneron Pharmaceuticals has shown strong revenue growth over the last two quarters. The revenue increased from $3.60 billion to $4.29 billion, reflecting an average increase of 16.0% per quarter.
POSITIVE IMPACTPrice Rise

In the last 7 days, REGN stock has moved up by 14.3%
NO EFFECTAgainst Peers

In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 375.5%
NO EFFECTAgainst Peers

In the last 3 years, Revolution Medicines, Inc. Common Stock has given 488.1% return, outperforming this stock by 489.2%
About Regeneron Pharmaceuticals Inc.
| Organisation | Regeneron Pharmaceuticals Inc. |
| Headquarters | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
| Industry | Biotechnology |
| CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Regeneron Pharmaceuticals Inc.
Name | Title |
|---|---|
Dr. Leonard S. Schleifer M.D., Ph.D. | Co-Founder, President, CEO & Co-Chairman |
Dr. George D. Yancopoulos M.D., Ph.D. | Co-Founder, President, Chief Scientific Officer & Co-Chairman |
Mr. Ryan Crowe | Senior Vice President of Investor Relations & Strategic Analysis |
Ms. Melissa Lozner | Senior VP & Chief Compliance Officer |
Mr. Christopher R. Fenimore CPA | Executive VP of Finance & CFO |
Mr. Joseph J. LaRosa J.D. | Executive VP, General Counsel & Secretary |
Dr. Andrew J. Murphy Ph.D. | Executive VP of Research & Co-Chief Scientific Officer |
Mr. Daniel P. Van Plew | Executive VP and GM of Industrial Operations & Product Supply |
Mr. Rajesh Ahuja | Senior Vice President of Quality Assurance & Operations |
Mr. Ryan Steinberger | Executive VP, Chief Digital & Technology Officer |
FAQs
What is Regeneron Pharmaceuticals Inc. share price today?
Regeneron Pharmaceuticals Inc. share price today is $763.98 as on . Regeneron Pharmaceuticals Inc. share today touched a day high of $771.95 and a low of $759.25.
What is the 52 week high and 52 week low for Regeneron Pharmaceuticals Inc. share?
Regeneron Pharmaceuticals Inc. share touched a 52 week high of $821.11 on and a 52 week low of $541.00 on . Regeneron Pharmaceuticals Inc. stock price today i.e. is trending at $763.98,which is 6.96% down from its 52 week high and 41.22% up from its 52 week low.
What is Regeneron Pharmaceuticals Inc.'s market capitalisation today?
Regeneron Pharmaceuticals Inc. market capitalisation is $0.08T as on .
How to invest in Regeneron Pharmaceuticals Inc. Stock (REGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Regeneron Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regeneron Pharmaceuticals Inc. Shares that will get you 0.0020 shares as per Regeneron Pharmaceuticals Inc. share price of $763.98 per share as on August 3, 2026 at 7:38 pm IST.
What is the minimum amount required to buy Regeneron Pharmaceuticals Inc. Stock (REGN) from India?
Indian investors can start investing in Regeneron Pharmaceuticals Inc. (REGN) shares with as little as ₹95.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.35 in Regeneron Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Regeneron Pharmaceuticals Inc. share’s latest price of $763.98 as on August 3, 2026 at 7:38 pm IST, you will get 0.0131 shares of Regeneron Pharmaceuticals Inc.. Learn more about
fractional shares .
What are the returns that Regeneron Pharmaceuticals Inc. has given to Indian investors in the last 5 years?
Regeneron Pharmaceuticals Inc. stock has given 30.03% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?